BioInformatics, LLC Launches Life Science Market Research Webinar Series

BioInformatics, LLC, a leading provider of market research and consulting services to the life sciences industry, today announced a series of upcoming webinars to provide insight to life science suppliers across a wide spectrum of marketing challenges and market research needs. The webinars are complimentary but require pre-registration to participate.

ARLINGTON, Va. (Business Wire EON) October 10, 2007 --

October 23, 2007 at 11:00 am EDT

Webinar: Improving Sales Rep Performance

October 30, 2007 at 11:00 am EDT

Webinar: Brand Positioning

November 7, 2007 at 1:00 pm EST

Webinar: Brand Positioning

November 14, 2007 at 11:00 am EST

Webinar: Maximizing the Effectiveness of Market Research

November 28, 2007 at 11:00 am EST

Webinar: Brand Positioning

December 5, 2007 at 11:00 EST

Webinar: Marketing to Life Scientists - India & China

December 11, 2007 at 1:00 am EST

Webinar: Marketing to Life Scientists - India & China

December 13, 2007 at 1:00 pm EST

Webinar: Maximizing the Effectiveness of Market Research

John Lewis, Vice President of Marketing and Business Development for BioInformatics, said, "These webinars highlight the findings of our published research in the areas of marketing and branding in the life sciences industry. Additionally, a new webinar in our series, 'Maximizing the Effectiveness of Market Research,' provides a roadmap for designing high-impact custom research programs."

For more information on upcoming webinars from BioInformatics, please visit http://www.gene2drug.com/about/events.asp

ABOUT BIOINFORMATICS, LLC

BioInformatics, LLC is the premier research and consulting firm serving the life science tools industry. By leveraging our professional social network of tens of thousands of biomedical researchers, we have supported more than 300 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

Suggested Articles

Inovio CEO J. Joseph Kim is undeterred by short sellers and other detractors who doubt his company can shuttle a COVID-19 DNA vaccine to market.

Adding entinostat to hormone therapy did not help patients with HR-positive, HER2-negative breast cancer live longer.

The data add to the evidence in support of the IL-6 drug ahead of a FDA decision to approve it in a rare disease served by Alexion’s Soliris.